Back To Archive


This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.

FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, August 6, 2026

Download

ASCVD Revisited: Frequently Asked Questions from the OMNS ASCVD Forum

Introducing the I-OM.ai ASCVD Coach

By Richard Z. Cheng, MD, PhD
Editor-in-Chief, Orthomolecular Medicine News Service (OMNS)


Introduction

On July 25, 2026, the Orthomolecular Medicine News Service (OMNS) hosted the online forum "ASCVD Revisited," featuring presentations by Dr. Thomas E. Levy and Dr. Richard Z. Cheng. The forum explored current perspectives on atherosclerotic cardiovascular disease (ASCVD), including vascular biology, endothelial dysfunction, nutrition, orthomolecular medicine, and the potential for improving vascular health through a systems-oriented approach.

The presentations stimulated lively discussion and generated numerous thoughtful questions from participants. Although many questions were addressed during the live forum, many others naturally arise only after readers have had time to reflect on the material.

To continue the educational discussion beyond the forum, we developed the I-OM.ai ASCVD Coach-an interactive educational AI built using the principles of I-OM Systems Medicine.

While a traditional recording allows viewers to watch a presentation from beginning to end, an interactive educational AI offers a different learning experience. Rather than passively viewing a lecture, readers can ask their own questions, request clarification, explore controversial topics, examine specific biomarkers or therapies, revisit concepts at their own pace, and continue the discussion as long as they wish.

We believe this question-driven, interactive approach provides a more personalized and effective way to learn complex medical concepts.

Unlike a traditional article or recorded presentation, the ASCVD Coach allows readers to ask their own specific questions and receive educational explanations in real time. Whether someone wishes to understand a fundamental concept such as "What is ApoB?", explore a controversial topic such as "Does saturated fat cause heart disease?", examine whether ASCVD or coronary plaque can regress, or request the original ASCVD Forum presentation slides by Dr. Thomas E. Levy and Dr. Richard Z. Cheng, the Coach is designed to provide clear, evidence-informed responses while distinguishing among:

  • established scientific evidence;
  • emerging or debated hypotheses;
  • conventional cardiovascular interpretations; and
  • the I-OM Systems Medicine perspective.

The Coach can also explain individual slides, figures, mechanisms, references, and clinical cases presented in the original forum presentations, allowing readers to continue learning through an interactive, question-driven discussion.

The public beta is available at:

https://i-om.ai

Readers are encouraged to ask the Coach their own ASCVD questions and provide feedback as the platform continues to develop.


Appendix A. Benchmark Validation of the I-OM.ai ASCVD Coach

A.1 Benchmark Objectives

The I-OM.ai ASCVD Coach was evaluated using a structured set of benchmark questions designed to assess its ability to provide scientifically accurate, balanced, educational, and clinically responsible responses consistent with the principles of I-OM Systems Medicine.

The benchmark questions were selected to represent major domains of ASCVD education, including:

  • disease biology;
  • vascular physiology;
  • risk factors;
  • prevention and diagnosis;
  • conventional therapies;
  • nutrition;
  • metabolic health;
  • orthomolecular medicine;
  • controversial topics; and
  • public educational resource retrieval.

Each response was evaluated for:

  • scientific accuracy;
  • consistency with the I-OM Systems Medicine framework;
  • balance between conventional and I-OM perspectives;
  • educational clarity;
  • appropriate acknowledgment of uncertainty;
  • safety; and
  • practical usefulness.

Responses were graded using the following qualitative scale:

Grade Interpretation

10/10 Excellent; publication-quality response with no substantive revision required

9.0-9.9/10 Very good to excellent; only minor wording or emphasis improvements suggested

Below 9/10 Revision required before public release


A.2 Benchmark Questions and Results

Benchmark Questions and Results


A.3 Overall Performance

The benchmark evaluation demonstrated that the I-OM.ai ASCVD Coach consistently produced responses that were:

  • scientifically accurate;
  • educational and understandable;
  • balanced between conventional cardiovascular medicine and the I-OM Systems Medicine framework;
  • careful to distinguish established evidence from emerging or debated hypotheses;
  • clinically responsible and safety-conscious;
  • responsive to the user's specific question;
  • capable of explaining complex topics in accessible language; and
  • capable of retrieving original public educational resources when available.

Across the benchmark set, the average evaluation score exceeded 9.9/10, and no response required substantive scientific revision before public beta release.

These benchmark questions represent only a sample of the Coach's capabilities. The primary advantage of the I-OM.ai ASCVD Coach is its interactive nature. Readers are not limited to the questions presented in this article. They may ask their own questions, request clarification, pursue follow-up questions, examine controversial topics, or explore specific biomarkers, dietary approaches, medications, mechanisms, or imaging findings.

The Coach can also direct users to original educational materials, including the ASCVD Forum presentations by Dr. Tom Levy and Dr. Richard Cheng, and then help readers interpret particular slides, figures, mechanisms, references, or conclusions.

Rather than replacing traditional articles, lectures, or clinical conversations, the I-OM.ai ASCVD Coach is intended to extend them by offering on-demand, question-driven educational dialogue grounded in the principles of I-OM Systems Medicine.


Reader Discussion and Questions

OMNS welcomes comments, questions, ideas, experiences, and respectful dialogue from readers, patients, healthcare professionals, researchers, and students worldwide.

We encourage participation on OMNS Interactive, where the exchange of knowledge and perspectives helps advance understanding and foster meaningful discussion.

Join the conversation:
https://omns.substack.com


About OMNS Interactive

OMNS Interactive is the discussion and commentary platform of the Orthomolecular Medicine News Service (OMNS).

The original OMNS website remains the official archive of OMNS publications.

Subscribe to OMNS Interactive for future articles, commentary, and discussions:
https://omns.substack.com

Content is provided for educational purposes only and does not constitute medical advice.

Follow OMNS Interactive

OMNS Interactive


Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Jennifer L. Aliano, M.S., L.Ac., C.C.N. (USA)
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Greg Beattie, Author (Australia)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Fabrice Leu, N.D., (Switzerland)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Diana MacKay (Gifford-Jones), M.P.P. (Canada)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Dr.Aarti Midha M.D., ABAARM (India)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiwei Ning, M.D., Ph.D. (China)
Zhiyong Peng, M.D. (China)
Pawel Pludowski, M.D. (Poland)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Ulrich G. T. Strunz Ph.D. (Germany)
Jagan Nathan Vamanan, M.D. (India)
Dr. Sunil Wimalawansa, M.D., Ph.D. (Sri Lanka)

Andrew W. Saul, Ph.D. (USA), Founding & Former Editor
Richard Cheng, M.D., Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, Arabic Edition: Ayman Kamel, DVM, MBA (Egypt)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.


To Subscribe at no charge: https://www.orthomolecular.org/subscribe.html

To Unsubscribe from this list: https://www.orthomolecular.org/unsubscribe.html

Back To Archive

[Home] [History] [Library] [Nutrients] [Resources] [Contact] [Contribute]
Back To Molecule

This website is managed by Riordan Clinic
A Non-profit 501(c)(3) Medical, Research and Educational Organization
3100 North Hillside Avenue, Wichita, KS 67219 USA
Phone: 316-682-3100; Fax: 316-682-5054
© (Riordan Clinic) 2004 - 2024c

Information on Orthomolecular.org is provided for educational purposes only. It is not intended as medical advice.
Consult your orthomolecular health care professional for individual guidance on specific health problems.